Immunotherapy Drugs Market - Global Industry Analysis

Immunotherapy Drugs Market by Drug Type (Adult Vaccines, Monoclonal Antibodies, Checkpoint Inhibitors, Interleukins, Interferon Alpha & Beta, and Others), by Therapeutic Application (Autoimmune & Inflammatory Diseases, Cancer, Infectious Diseases, and Others), and by End-User (Hospitals, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2025

Published Date: 28-Jan-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-1811 Status : Published

Global immunotherapy drugs market expected to generate around USD 330.4 billion by 2025, at a CAGR of around 13.24% between 2019 and 2025. Immunotherapy, also referred to as biological therapy, uses the body’s natural defense system to fight cancer cells and other infections.

Description

The report covers a forecast and an analysis of the immunotherapy drugs market on a global and regional level. The study provides historical data from 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the immunotherapy drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immunotherapy drugs market on a global and regional level.

In order to give the users of this report a comprehensive view of the immunotherapy drugs market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Immunotherapy Drugs Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immunotherapy drugs market on a global and regional basis.

The study provides a decisive view of the immunotherapy drugs market by segmenting the market based on drug type, therapeutic applications, end-user, and region. By drug type, the market is segmented into adult vaccines, monoclonal antibodies, checkpoint inhibitors, interleukins, interferon alpha and beta, and others. Preventive vaccines and therapeutic vaccines comprise the adult vaccines segment. By therapeutic application, this global market is segmented into autoimmune and inflammatory diseases, cancer, infectious diseases, and others. Cancer segment is further divided into the solid tumor and malignant. Hospitals, clinics, and others form the end-user segment of the global immunotherapy drugs market.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S. Canada, Germany, France, the UK, China, Japan, India, and Brazil.

Some key players of the immunotherapy drugs market include F. Hoffmann-La Roche AG, Amgen, Inc., Novartis International AG, AbbVie, Inc., Merck & Co., Inc., GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, and Johnson & Johnson, among others.

This report segments the global immunotherapy drugs market into:

Global Immunotherapy Drugs Market: By Drug Type

  • Monoclonal Antibodies
  • Adult Vaccines
    • Preventive Vaccines
    • Therapeutic Vaccines
  • Checkpoint Inhibitors
  • Interferons Alpha and Beta
  • Interleukins
  • Others

Global Immunotherapy Drugs Market: By Therapeutic Application

  • Cancer
    • Solid Tumor
    • Malignant
  • Autoimmune and Inflammatory Diseases
  • Infectious Diseases
  • Others

Global Immunotherapy drugs Market: By End-User

  • Hospitals
  • Clinics
  • Others

Global Immunotherapy Drugs Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Immunotherapy Drugs Market Revenue, 2016 - 2025 (USD Billion)
    • 2.2. Global Immunotherapy Drugs Market: Snapshot
  •  
  • Chapter 3. Immunotherapy Drugs Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Immunotherapy Drugs Market drivers: Impact analysis
      • 3.2.2. Increasing Preference for Targeted Therapy Over Traditional Therapy
      • 3.2.3. Emergence of Biosimilars
    • 3.3. Market Restraints
      • 3.3.1. High Cost of Immunotherapy Treatment
    • 3.4. Opportunities
      • 3.4.1. Emerging Markets
    • 3.5. Porter’s Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Drug Type
      • 3.6.2. Market attractiveness analysis, by Therapeutic Application
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Immunotherapy Drugs Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Immunotherapy Drugs Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapeutic Application Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Immunotherapy Drugs Market - Drug Type Analysis
    • 5.1. Global Immunotherapy Drugs Market: Drug Type overview
      • 5.1.1. Global Immunotherapy Drugs Market revenue share, by Drug Type, 2018 and 2025
    • 5.2. Monoclonal Antibodies
      • 5.2.1. Global Immunotherapy Drugs Market for Monoclonal Antibodies, 2016 - 2025(USD Billion)
    • 5.3. Adult Vaccines
      • 5.3.1. Global Immunotherapy Drugs Market for Adult Vaccines, 2016 - 2025 (USD Billion)
    • 5.4. Checkpoint Inhibitors
      • 5.4.1. Global Immunotherapy Drugs Market for Checkpoint Inhibitors, 2016 - 2025 (USD Billion)
    • 5.5. Interferons Alpha & Beta
      • 5.5.1. Global Immunotherapy Drugs Market for Interferons Alpha & Beta, 2016 - 2025 (USD Billion)
    • 5.6. Interleukins
      • 5.6.1. Global Immunotherapy Drugs Market for Interleukins, 2016 - 2025 (USD Billion)
    • 5.7. Others
      • 5.7.1. Global Immunotherapy Drugs Market for Others, 2016 - 2025 (USD Billion)
  •  
  • Chapter 6. Global Immunotherapy Drugs Market - Therapeutic Application Analysis
    • 6.1. Global Immunotherapy Drugs Market: Therapeutic Application overview
      • 6.1.1. Global Immunotherapy Drugs Market revenue share, by Therapeutic Application, 2018 and 2025
    • 6.2. Cancer
      • 6.2.1. Global Immunotherapy Drugs Market for Cancer, 2016 - 2025 (USD Billion)
    • 6.3. Autoimmune and Inflammatory Diseases
      • 6.3.1. Global Immunotherapy Drugs Market for Autoimmune and Inflammatory Diseases, 2016 - 2025(USD Billion)
    • 6.4. Infectious Diseases
      • 6.4.1. Global Immunotherapy Drugs Market for Infectious Diseases, 2016 - 2025 (USD Billion)
    • 6.5. Others
      • 6.5.1. Global Immunotherapy Drugs Market for Others, 2016 - 2025 (USD Billion)
  •  
  • Chapter 7. Global Immunotherapy Drugs Market - End-User Analysis
    • 7.1. Global Immunotherapy Drugs Market: End-User overview
      • 7.1.1. Global Immunotherapy Drugs Market revenue share, by End-User, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Immunotherapy Drugs Market for Hospitals, 2016 - 2025(USD Billion)
    • 7.3. Clinics
      • 7.3.1. Global Immunotherapy Drugs Market for Clinics, 2016 - 2025(USD Billion)
    • 7.4. Others
      • 7.4.1. Global Immunotherapy Drugs Market for Others, 2016 - 2025(USD Billion)
  •  
  • Chapter 8. Global Immunotherapy Drugs Market - Regional Analysis
    • 8.1. Global Immunotherapy Drugs Market: Regional overview
      • 8.1.1. Global Immunotherapy Drugs Market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.2.2. North America Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.2.3. North America Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.2.4.2. The U.S. Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.2.4.3. The U.S. Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.2.5.2. Rest of North America Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.2.5.3. Rest of North America Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.3.2. Europe Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.3.3. Europe Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.3.4.2. Germany Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.3.4.3. Germany Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.3.5.2. UK Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.3.5.3. UK Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.3.6.2. France Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.3.6.3. France Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.3.7.2. Rest of Europe Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.3.7.3. Rest of Europe Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pa
      • cific Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.4.2. Asia Pacific Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.4.3. Asia Pacific Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.4.4.2. China Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.4.4.3. China Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.4.5.2. Japan Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.4.5.3. Japan Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.4.6.2. India Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.4.6.3. India Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.5.2. Latin America Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.5.3. Latin America Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.5.4.2. Brazil Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.5.4.3. Brazil Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.6.2. The Middle East and Africa Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.6.3. The Middle East and Africa Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. F. Hoffmann-La Roche AG
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. GlaxoSmithKline
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. AbbVie, Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Amgen, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Merck & Co., Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Bristol-Myers Squibb
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Novartis International AG
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Eli Lilly and Company
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Johnson & Johnson
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. AstraZeneca Plc
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research application
2. Market research methodology
3. Global Immunotherapy Drugs Market revenue, 2016 – 2025(USD Billion) 
4. Porter’s Five Forces analysis
5. Immunotherapy Drugs Market attractiveness analysis, by Drug Type
6. Immunotherapy Drugs Market attractiveness analysis, by Therapeutic Application
7. Immunotherapy Drugs Market attractiveness analysis, by End-User
8. Immunotherapy Drugs Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global Immunotherapy Drugs Market revenue share by Drug Type, 2018 and 2025
11. Global Immunotherapy Drugs Market for Monoclonal Antibodies, 2016 – 2025 (USD Billion)
12. Global Immunotherapy Drugs Market for Adult Vaccines, 2016 – 2025 (USD Billion)
13. Global Immunotherapy Drugs Market for Checkpoint Inhibitors, 2016 – 2025 (USD Billion)
14. Global Immunotherapy Drugs Market for Interferons Alpha & Beta, 2016 – 2025 (USD Billion)
15. Global Immunotherapy Drugs Market for Interleukins, 2016 – 2025 (USD Billion)
16. Global Immunotherapy Drugs Market for Others, 2016 – 2025 (USD Billion)
17. Global Immunotherapy Drugs Market revenue share by Therapeutic Application, 2018 and 2025
18. Global Immunotherapy Drugs Market for Cancer, 2016 – 2025(USD Billion)
19. Global Immunotherapy Drugs Market for Autoimmune and Inflammatory Diseases, 2016 – 2025(USD Billion)
20. Global Immunotherapy Drugs Market for Infectious Diseases, 2016 – 2025 (USD Billion)
21. Global Immunotherapy Drugs Market for Others, 2016 – 2025 (USD Billion)
22. Global Immunotherapy Drugs Market revenue share by End-User, 2018 and 2025
23. Global Immunotherapy Drugs Market for Hospitals, 2016 – 2025(USD Billion)
24. Global Immunotherapy Drugs Market for Clinics, 2016 – 2025(USD Billion)
25. Global Immunotherapy Drugs Market for Others, 2016 – 2025(USD Billion)
26. North America Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)
27. Europe Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)
28. Asia Pacific Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)
29. Latin America Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)
30. The Middle East and Africa Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)


Table Of Tables

List of Tables

1. Immunotherapy Drugs Market: Market Snapshot                                                                                                                        
2. Drivers of Global Immunotherapy Drugs Market: Impact analysis 
3. Restraints of Global Immunotherapy Drugs Market: Impact analysis  
4. North America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025(USD Billion)
5. North America Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
6. North America Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025(USD Billion)
7. North America Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
8. North America Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025(USD Billion)
9. The U.S. Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
10. The U.S. Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
11. The U.S. Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
12. The U.S. Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
13. The U.S. Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
14. Rest of North America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
15. Rest of North America Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
16. Rest of North America Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
17. Rest of North America Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
18. Rest of North America Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
19. Europe Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
20. Europe Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
21. Europe Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
22. Europe Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
23. Europe Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
24. Germany Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
25. Germany Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
26. Germany Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
27. Germany Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
28. Germany Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
29. UK Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
30. UK Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
31. UK Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
32. UK Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
33. UK Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
34. France Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
35. France Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
36. France Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
37. France Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
38. France Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
39. Rest of Europe Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
40. Rest of Europe Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
41. Rest of Europe Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
42. Rest of Europe Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
43. Rest of Europe Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
44. Asia Pacific Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
45. Asia Pacific Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
46. Asia Pacific Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
47. Asia Pacific Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
48. Asia Pacific Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
49. China Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
50. China Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
51. China Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
52. China Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
53. China Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
54. Japan Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
55. Japan Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
56. Japan Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
57. Japan Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
58. Japan Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
59. India Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
60. India Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
61. India Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
62. India Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
63. India Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
64. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
65. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
66. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
67. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
68. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
69. Latin America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
70. Latin America Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
71. Latin America Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
72. Latin America Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
73. Latin America Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
74. Brazil Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
75. Brazil Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
76. Brazil Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
77. Brazil Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
78. Brazil Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
79. Rest of Latin America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
80. Rest of Latin America Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
81. Rest of Latin America Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
82. Rest of Latin America Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
83. Rest of Latin America Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
84. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
85. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
86. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
87. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
88. The Middle East and Africa Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)

Methodology

Free Analysis

Immunotherapy uses the body’s immune system to fight against various disorders, such as cancer, infectious diseases, autoimmune, and inflammatory diseases. Immunotherapy includes the use of monoclonal antibodies and various checkpoint inhibitors that disrupt signals that protect cancer cells from immune attack, preventive, and therapeutic vaccines, and cytokines, such as interferon, interleukin etc. Immunotherapy is widely adopted in cancer treatments, owing to lesser side-effects as compared to chemotherapy.

The prevalence of cancer is growing worldwide and it was the second leading cause of death in the year 2018. As per the World Health Organization (WHO) 2018 estimates, there were about 18.1 million new cancer cases and 9.6 million global deaths caused by cancer. The incidence of lifestyle-related disorders is rapidly increasing, which, in turn, is likely to drive the demand for immunotherapy drugs market in the future. The increasing preference for targeted therapy with lesser side-effects over traditional therapy is anticipated to further fuel the immunotherapy drugs market in the future. Additionally, the emergence of new biosimilars, rapid drug approvals, and increased demand for monoclonal antibodies (mAbs) are projected to boost the immunotherapy drugs market growth over the estimated timeframe. Other factors likely to contribute toward the immunotherapy drugs market growth are rising geriatric population base, increasing health awareness, increased disposable income and healthcare spending, and favorable reimbursement policies. However, the high cost of immunotherapy drugs might limit the immunotherapy drugs market in the future. Emerging markets and immunotherapy as a substitute for chemotherapy is likely to create new growth opportunities for the immunotherapy drugs market on a global scale.

Global Immunotherapy Drugs Market

The global immunotherapy drugs market is segmented based on drug type, therapeutic application, and end-user. By drug type, the market is segmented into adult vaccines, monoclonal antibodies, checkpoint inhibitors, interleukins, interferon alpha and beta, and others. Preventive vaccines and therapeutic vaccines comprise the adult vaccines segment. Monoclonal antibodies drug type segment held the largest share of the global immunotherapy drug market in 2017, owing to the preference for targeted therapy with lesser side effects. By therapeutic application, this global market is segmented into autoimmune and inflammatory diseases, cancer, infectious diseases, and others. Cancer segment is further divided into the solid tumor and malignant. The cancer therapeutic application segment held the largest share of global immunotherapy drugs market, owing to increasing cancer prevalence globally. Hospitals, clinics, and others form the end-user segment of the global immunotherapy drugs market. Hospitals dominated the immunotherapy drugs market in 2017 and are expected to lead in the future as well.

By region, North America dominated the global immunotherapy drugs market in 2018 with a revenue share of about 40%. This can be attributed to the presence of key players, increasing preference for targeted immunotherapy over other therapies, favorable reimbursement policies, and developed healthcare infrastructure. North America is likely to maintain its top position over the forecast time period as well. Europe is the second largest regional market for immunotherapy drugs in 2018. The Asia Pacific region is estimated to register the highest CAGR over the forecast time period, owing to increasing health awareness, growing healthcare spending, and rising disposable income. The Middle Eastern and African region is likely to experience noticeable growth in the years ahead. Latin America is projected to exhibit a moderate rate of growth for immunotherapy drugs market over the forecast time period.

Some key players of the immunotherapy drugs market include F. Hoffmann-La Roche AG, Amgen, Inc., Novartis International AG, AbbVie, Inc., Merck & Co., Inc., GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, and Johnson & Johnson, among others.

Choose License Type

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed